Article
The prognostic value of the interaction between ASXL1 and TET2 gene mutations in patients with chronic myelomonocytic leukemia: a meta-analysis.
Hematology (Amsterdam, Netherlands) - 1 Dec 2022
Zhao Wenxia, Zhang Conghui, Li Yiming, Li Yang, Liu Yang, Sun Xiaoyu, Liu Mingyan, Shao Rongguang
Abstract excerpt
PURPOSE: The prognostic role of TET2 and/or ASXL1 mutations which are common gene mutations in chronic myelomonocytic leukemia (CMML) remains controversial. Therefore, we conducted this meta-analysis to evaluate the prognostic efficacy of ASXL1 and TET2 mutations in CMML population. METHODS: PubMed, Cochrane and Embase for relevant research were employed to identify 16 studies. Overall survival rate (OS) with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
